Engine manufacturer Cummins (NYSE:CMI) reported revenue ahead of Wall Street’s expectations in Q4 CY2024, but sales fell by 1 ...

Reports Q4 revenue $8.45B, consensus $8.09B. The current quarter results include Accelera reorganization actions of $312M, or $2.14 per diluted ...

Barclays raised the firm’s price target on Cummins (CMI) to $381 from $310 and keeps an Equal Weight rating on the shares post the Q4 report.

The Columbus, Indiana-based company said it had net income of $3.02 per share. Earnings, adjusted for non-recurring costs, came to $5.16 per share. The results topped Wall Street expectations. The ...

Shrugging off Monday weakness, Cummins (NYSE: CMI) stock rebounded this morning and was trading 4.7% higher as of noon ET Tuesday. The industrial giant posted fourth-quarter and full-year earnings ...

The S&P 500 Index ($SPX) (SPY) today is up +0.15%, the Dow Jones Industrials Index ($DOWI) (DIA) is down -0.08%, and the ...

Stocks extended their gains on Tuesday on strength in megacap technology stocks. Stocks moved higher Tuesday despite the US imposing a 10% tariff on Chinese goods.  China retaliated immediately and ...

Equities researchers at B. Riley lowered their Q4 2024 earnings per share (EPS) estimates for Magnite in a research report issued on Monday, January 27th. B. Riley analyst Z. Cummins now anticipates ...

Equities researchers at B. Riley reduced their Q1 2025 earnings estimates for shares of PubMatic in a research note issued on Monday, January 27th. B. Riley analyst Z. Cummins now expects that the ...

RBC Capital lowered the firm’s price target on Liberty Energy (LBRT) to $24 from $26 and keeps an Outperform rating on the shares after its Q4 results ... January 29, 2025--Cummins Inc ...

Comcast said fourth quarter profit surged as the company saw good results at its mobile business, at the box office and at its Peacock streaming hub. Meanwhile, the Philadelphia cable-and ...

AbbVie Q4 adjusted EPS of $2.16 beat estimates, with strong sales of Skyrizi (+57.9%) and Rinvoq (+47.1%) boosting revenue growth. AbbVie raises 2027 revenue forecast for Skyrizi and Rinvoq to $31 ...